Clinical Trial Update: Rezvilutamide for High-Risk Prostate Cancer After Surgery [NA]

View source ↗

Summary

A clinical trial evaluating rezvilutamide for high-risk prostate cancer after surgery is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Rezvilutamide (rezvilutamide)

Snippet

Sponsor: Fujian Medical University Union Hospital | Conditions: Prostate Cancer (Adenocarcinoma) | NA | Status: NOT_YET_RECRUITING